Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Haleon plc

HLNCFPNK
Healthcare
Drug Manufacturers - Specialty & Generic
$5.15
$0.12(2.39%)
U.S. Market opens in NaNh NaNm

Haleon plc (HLNCF) Stock Overview

Explore Haleon plc’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap45.9B
P/E Ratio23.76
EPS (TTM)$0.23
ROE0.09%
Fundamental Analysis

AI Price Forecasts

1 Month$5.66
3 Months$6.51
1 Year Target$5.48

HLNCF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Haleon plc (HLNCF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 46.14, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $5.48.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 23.76 and a market capitalization of 45.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
2.39%
5-Day Change
-8.85%
1-Month Change
-0.39%
3-Month Change
5.32%
6-Month Change
6.19%
Year-to-Date (YTD) Change
7.52%
1-Year Change
1.98%
3-Year Change
47.99%
5-Year Change
47.99%
All-Time (Max) Change
47.99%

Contact Information

44 1932 822000
Building 5, Weybridge, KT13 0NY

Company Facts

24,561 Employees
IPO DateJul 28, 2022
CountryGB
Actively Trading

Frequently Asked Questions